If you watch TV, you may have seen commercials for AndroGel. In the commercial, a fit, good-looking middle-aged man bashfully admits to having low testosterone or “low T.” As he lists the symptoms of low T, he is joined by a pretty woman. They dine, shop, and sightsee while the commercial explains how AndroGel reverses low levels of testosterone, making men feel younger and healthier. The commercial ends with a sunset.
The commercials make it seem like AndroGel is a miracle cure that will bring back a man’s youth and energy. AndroGel users do report feeling younger, being more active, and having an increased sex drive. Testosterone therapy also helps men lose fat and build muscle.
But there is a dark side to the drug. Recent research shows that testosterone treatment may increase the risk of heart attack, stroke, and death in some users.
Study Stopped Because AndroGel Users Had Too Many Heart Attacks
A 2010 study tracked the health of 209 older men with low testosterone. The average age of the men was 74. Many of the participants had other medical conditions such as heart disease, hypertension, and diabetes. Half the men were given testosterone gel; the other half received a placebo. The study was discontinued after a spike in heart attacks among the men using the testosterone gel. The results were published in the New England Journal of Medicine.
Large Scale Study Links AndroGel to Heart Attacks
A 2013 study of veterans found that some men may face a significantly higher risk of heart attack, stroke, and death after treatment with Androgel. The study included 8,700 men with an average age of 60. Each of the participants had a testosterone level below 300 and had received a coronary angiography due to plaque buildup in the arteries. The researchers compared the health histories of the 1,223 veterans who received testosterone replacement treatment with the 7,489 men who were not using testosterone. The rate of adverse events such as heart attack, stroke, and death was 25.7 percent for testosterone users compared to 19.9 percent in non-users.
2014 Study Finds Risk is Highest in Men Over 65
A January 2014 study of 55,000 men with low testosterone found that men age 65 and older who used testosterone therapy had twice the risk of heart attack as similar-aged men who were not being treated for low T. The study also found an increased risk of heart attack in younger men who had existing heart conditions.
AndroGel commercials and labels don’t warn of the risk of heart attacks.
If you suffered a heart attack or stroke after beginning testosterone treatment, you deserve accountability. Contact Hupy and Abraham at 800-800-5678 to find if you qualify to participate in a class action lawsuit against AbbieVie Inc., the maker of AndroGel. There is no cost for the consultation. Our attorneys don’t get paid unless we get results.